Diéras, V., Rugo, H. S., Schnell, P., Gelmon, K., Cristofanilli, M., Loi, S., . . . Finn, R. S. (2018). Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer. J Natl Cancer Inst.
Citación estilo ChicagoDiéras, Véronique, et al. "Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer." J Natl Cancer Inst 2018.
Cita MLADiéras, Véronique, et al. "Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer." J Natl Cancer Inst 2018.
Precaución: Estas citas no son 100% exactas.